264 related articles for article (PubMed ID: 8428611)
1. Sickle cell vasoocclusion: many issues and some answers.
Kaul DK; Nagel RL
Experientia; 1993 Jan; 49(1):5-15. PubMed ID: 8428611
[TBL] [Abstract][Full Text] [Related]
2. Sickle erythrocyte-endothelial interactions in microcirculation: the role of von Willebrand factor and implications for vasoocclusion.
Kaul DK; Nagel RL; Chen D; Tsai HM
Blood; 1993 May; 81(9):2429-38. PubMed ID: 8481522
[TBL] [Abstract][Full Text] [Related]
3. Rate of deoxygenation modulates rheologic behavior of sickle red blood cells at a given mean corpuscular hemoglobin concentration.
Kaul DK; Liu XD
Clin Hemorheol Microcirc; 1999; 21(2):125-35. PubMed ID: 10599596
[TBL] [Abstract][Full Text] [Related]
4. Demonstration of endothelial adhesion of sickle cells in vivo: a distinct role for deformable sickle cell discocytes.
Fabry ME; Fine E; Rajanayagam V; Factor SM; Gore J; Sylla M; Nagel RL
Blood; 1992 Mar; 79(6):1602-11. PubMed ID: 1547349
[TBL] [Abstract][Full Text] [Related]
5. MEK1/2 inhibitors reverse acute vascular occlusion in mouse models of sickle cell disease.
Zhao Y; Schwartz EA; Palmer GM; Zennadi R
FASEB J; 2016 Mar; 30(3):1171-86. PubMed ID: 26631480
[TBL] [Abstract][Full Text] [Related]
6. [Pathophysiology of sickle cell disease].
Elion J; Laurance S; Lapouméroulie C
Med Trop (Mars); 2010 Dec; 70(5-6):454-8. PubMed ID: 21520646
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of sickle red cell adhesion and vasoocclusion in the microcirculation by antioxidants.
Kaul DK; Liu XD; Zhang X; Ma L; Hsia CJ; Nagel RL
Am J Physiol Heart Circ Physiol; 2006 Jul; 291(1):H167-75. PubMed ID: 16443674
[TBL] [Abstract][Full Text] [Related]
8. Microvascular sites and characteristics of sickle cell adhesion to vascular endothelium in shear flow conditions: pathophysiological implications.
Kaul DK; Fabry ME; Nagel RL
Proc Natl Acad Sci U S A; 1989 May; 86(9):3356-60. PubMed ID: 2497465
[TBL] [Abstract][Full Text] [Related]
9. Critical role of endothelial cell activation in hypoxia-induced vasoocclusion in transgenic sickle mice.
Belcher JD; Mahaseth H; Welch TE; Vilback AE; Sonbol KM; Kalambur VS; Bowlin PR; Bischof JC; Hebbel RP; Vercellotti GM
Am J Physiol Heart Circ Physiol; 2005 Jun; 288(6):H2715-25. PubMed ID: 15665055
[TBL] [Abstract][Full Text] [Related]
10. Sickle red cell microrheology and sickle blood rheology.
Ballas SK; Mohandas N
Microcirculation; 2004 Mar; 11(2):209-25. PubMed ID: 15280093
[TBL] [Abstract][Full Text] [Related]
11. In vivo studies of sickle red blood cells.
Kaul DK; Fabry ME
Microcirculation; 2004 Mar; 11(2):153-65. PubMed ID: 15280089
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous polymerization and adhesion under hypoxia in sickle cell disease.
Papageorgiou DP; Abidi SZ; Chang HY; Li X; Kato GJ; Karniadakis GE; Suresh S; Dao M
Proc Natl Acad Sci U S A; 2018 Sep; 115(38):9473-9478. PubMed ID: 30190429
[TBL] [Abstract][Full Text] [Related]
13. Sickle cell vasoocclusion: heterotypic, multicellular aggregations driven by leukocyte adhesion.
Frenette PS
Microcirculation; 2004 Mar; 11(2):167-77. PubMed ID: 15280090
[TBL] [Abstract][Full Text] [Related]
14. Rheology of sickle cells and its role in microcirculatory dynamics.
Chien S; Kaperonis AA; King RG; Lipowsky HH; Schmalzer EA; Sung LA; Sung KL; Usami S
Prog Clin Biol Res; 1987; 240():151-65. PubMed ID: 3615484
[TBL] [Abstract][Full Text] [Related]
15. 2015 Clinical trials update in sickle cell anemia.
Archer N; Galacteros F; Brugnara C
Am J Hematol; 2015 Oct; 90(10):934-50. PubMed ID: 26178236
[TBL] [Abstract][Full Text] [Related]
16. Small-molecule cyclic alpha V beta 3 antagonists inhibit sickle red cell adhesion to vascular endothelium and vasoocclusion.
Finnegan EM; Barabino GA; Liu XD; Chang HY; Jonczyk A; Kaul DK
Am J Physiol Heart Circ Physiol; 2007 Aug; 293(2):H1038-45. PubMed ID: 17483236
[TBL] [Abstract][Full Text] [Related]
17. Primary role for adherent leukocytes in sickle cell vascular occlusion: a new paradigm.
Turhan A; Weiss LA; Mohandas N; Coller BS; Frenette PS
Proc Natl Acad Sci U S A; 2002 Mar; 99(5):3047-51. PubMed ID: 11880644
[TBL] [Abstract][Full Text] [Related]
18. Overview of pathophysiology and rationale for treatment of sickle cell anemia.
Rodgers GP
Semin Hematol; 1997 Jul; 34(3 Suppl 3):2-7. PubMed ID: 9317195
[TBL] [Abstract][Full Text] [Related]
19. Polynitroxyl albumin inhibits inflammation and vasoocclusion in transgenic sickle mice.
Mahaseth H; Vercellotti GM; Welch TE; Bowlin PR; Sonbol KM; Hsia CJ; Li M; Bischof JC; Hebbel RP; Belcher JD
J Lab Clin Med; 2005 Apr; 145(4):204-11. PubMed ID: 15962839
[TBL] [Abstract][Full Text] [Related]
20. Exercise limitation, exercise testing and exercise recommendations in sickle cell anemia.
Connes P; Machado R; Hue O; Reid H
Clin Hemorheol Microcirc; 2011; 49(1-4):151-63. PubMed ID: 22214686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
